Cargando…
The effects of genes implicated in cardiovascular disease on blood-pressure response to treatment among treatment-naïve hypertensive African Americans in the GenHAT study
African Americans have the highest prevalence of hypertension in the United States. Blood-pressure control is important to reduce cardiovascular disease (CVD)-related morbidity and mortality in this ethnic group. Genetic variants have been found to be associated with BP response to treatment. Previo...
Autores principales: | Do, Anh N, Lynch, Amy I, Claas, Steven A, Boerwinkle, Eric, Davis, Barry R, Ford, Charles E, Eckfeldt, John H, Tiwari, Hemant K, Arnett, Donna K, Irvin, Marguerite R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956602/ https://www.ncbi.nlm.nih.gov/pubmed/26791477 http://dx.doi.org/10.1038/jhh.2015.121 |
Ejemplares similares
-
The effects of angiotensinogen gene polymorphisms on cardiovascular disease outcomes during antihypertensive treatment in the GenHAT study
por: Do, Anh N., et al.
Publicado: (2014) -
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT
por: Lynch, Amy I., et al.
Publicado: (2013) -
Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study
por: Zhang, Xue, et al.
Publicado: (2012) -
Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study
por: Armstrong, Nicole D., et al.
Publicado: (2022) -
RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment
por: Lynch, Amy I, et al.
Publicado: (2012)